📰 Abt News
Page 31 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
February 4, 2024
Northeast Investment Management lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,049 shares of the healthcare product maker’s stock after selling 3,496 shares during the quarter. Northeast Investment […]
February 4, 2024
Argent Trust Co increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 139,134 shares of the healthcare product maker’s stock after purchasing an additional 1,933 shares during the period. Abbott […]
February 4, 2024
Arcblock (ABT) traded up 49.2% against the US dollar during the 1 day period ending at 14:00 PM E.T. on February 4th. One Arcblock token can currently be purchased for about $0.78 or 0.00001819 BTC on popular exchanges. Over the last seven days, Arcblock has traded up 215.5% against the US dollar. Arcblock has a […]
February 3, 2024
Arcblock (ABT) traded up 47.5% against the dollar during the one day period ending at 21:00 PM Eastern on February 2nd. Arcblock has a market cap of $48.18 million and approximately $4.55 million worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can currently be bought for approximately $0.49 […]
February 3, 2024
Avantax Advisory Services Inc. decreased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 110,811 shares of the healthcare product maker’s stock after selling 1,941 shares during the period. Avantax Advisory […]
February 3, 2024
Banque Cantonale Vaudoise trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 130,379 shares of the healthcare product maker’s stock after selling 1,795 shares during the period. Abbott […]
February 3, 2024
Trillium Asset Management LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 19.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,627 shares of the healthcare product maker’s stock after selling 1,809 shares during […]
February 3, 2024
Penobscot Investment Management Company Inc. raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 14.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,954 shares of the healthcare product maker’s stock after buying an additional 7,117 shares during […]
February 3, 2024
Torray Investment Partners LLC lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 10.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,250 shares of the healthcare product maker’s stock after purchasing an additional 220 shares during the quarter. Torray Investment Partners LLC’s holdings […]
February 2, 2024
Kestra Private Wealth Services LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 101,652 shares of the healthcare product maker’s stock after purchasing an additional 9,470 shares during […]